PetLife
Financiado
INTRODUCTION OF A RANGE OF L-CYSTEINE DERIVATIVES AS NUTRITIONAL ADDITIVES IN PET FOOD, TO REDUCE OBESITY AND LENGTHEN ANIMAL LIFE
Veterinary research shows that up to 45% of cats and dogs suffer health disorders, with oxidative effects from nutritionalimbalances as a significant contributing factor. Of the approximately 270 million pets in the EU, 60% have c...
Veterinary research shows that up to 45% of cats and dogs suffer health disorders, with oxidative effects from nutritionalimbalances as a significant contributing factor. Of the approximately 270 million pets in the EU, 60% have commercial petfood exclusively as their source of nutrition and therefore depend on a complete and balanced product for health andwellbeing.The PetLife project is based on a promising market and growth opportunity deriving from our current L-Cysteine derivativeproduct line for use in plant nutrition. This latent cysteine is released into the plant gradually, providing its organism withseveral essential health benefits that extend to animals as well. AXEB is set to be the first in Europe and globally to validateand introduce L-cysteine derivatives as nutritional additives for animals, to solve the problem of providing cysteine withoutcausing nutritional imbalances and weight gain. The health benefits to be proved in phase 2 validation will convince petowners and feed manufacturers of the worth of these new added-value formulations.Our objective is to take advantage of our know-how in order to broaden the use of this innovative compound as an animalnutrient and access the EU pet food industry and European pet owners who spend up to €21,000 on each pet over itslifetime, and €55 per pet every year on veterinary care.When scaled up to industrial production, the proposed PetLife L-Cysteine derivatives will be commercialized with a targetprice 25% cheaper than current pet food additives, and provide more long-ranging health benefits to reduce end userveterinary expenses.Although we already possess the knowledge in biotechnology processes for molecule synthesis, we require assistance toenter the pet food market due to the rigorous regulatory approval process for new additives in the European market. Thepossibility of European funding will help us cross the ‘valley of death’ from development to marketplace.
ver más
Duración del proyecto: 5 meses
Fecha Inicio: 2016-03-01
Fecha Fin: 2016-08-31
Fecha Fin: 2016-08-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2016-08-31
H2020
No se conoce la línea exacta de financiación, pero conocemos el organismo encargado de la revisión del proyecto.
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
AXEB BIOTECH
No se ha especificado una descripción o un objeto social para esta compañía.
